Vivos (RDGL) EBITDA Margin (2010 - 2025)
Vivos (RDGL) reported EBITDA Margin of 4426.79% for Q4 2025, up 882246.0% on a YoY basis from N/an in Q4 2024, and up 84.34% sequentially from 28260.94% in Q3 2025.
Vivos (RDGL) EBITDA Margin (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 15 years of EBITDA Margin data on file, last reported at 4426.79% in Q4 2025.
- For the quarter ending Q4 2025, EBITDA Margin rose 882246.0% year-over-year to 4426.79%; the trailing twelve-month figure through Dec 2025 stood at 4628.68% (up 467435.0% YoY), and the FY2025 full-year result was 4628.68%, up 467435.0% from the prior year.
- EBITDA Margin grew to 4426.79% in Q4 2025, from 28260.94% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 1307.07% in Q3 2021 to a low of 28260.94% in Q3 2025.
- A 5-year average of 9058.02% and a median of 6625.15% in 2022 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin soared 1019881 bps in 2024 and tumbled 1139804 bps in 2025, its largest moves.
- Tracing RDGL's EBITDA Margin over 5 years: stood at 1307.07% in 2021, then plunged by 731 bps to 10857.87% in 2022, then advanced by 10 bps to 9823.33% in 2023, then tumbled by 35 bps to 13249.25% in 2024, then soared by 67 bps to 4426.79% in 2025.
- Business Quant data shows RDGL's EBITDA Margin at 4426.79% in Q4 2025, 28260.94% in Q3 2025, and 4498.48% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 21.42% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 10.04% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 6.17% |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | -4,426.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4,426.79% |
| Sep 30, 2025 | -28,260.94% |
| Jun 30, 2025 | -4,498.48% |
| Mar 31, 2025 | -3,228.40% |
| Dec 31, 2024 | -13,249.25% |
| Sep 30, 2024 | -16,862.90% |
| Jun 30, 2024 | -3,868.96% |
| Mar 31, 2024 | -12,825.09% |
| Sep 30, 2023 | -9,823.33% |
| Jun 30, 2023 | -14,067.77% |
| Mar 31, 2023 | -4,138.63% |
| Dec 31, 2022 | -10,857.87% |
| Sep 30, 2022 | -4,262.54% |
| Jun 30, 2022 | -7,500.36% |
| Mar 31, 2022 | -5,749.95% |
| Sep 30, 2021 | -1,307.07% |
| Sep 30, 2020 | -1,834.86% |
| Dec 31, 2019 | -21,636.87% |
| Sep 30, 2019 | -7,590.09% |
| Mar 31, 2017 | -8,996.42% |